CRISPR/Cas3-engineered bacteriophages (Locus Biosciences)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameCRISPR/Cas3-engineered bacteriophages (Locus Biosciences)
Drug Alias NameN/A
ClassificationBiologics > Bacteriophages
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsClostridium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLocus Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLocus Biosciences Inc
Active IndicationsN/A
Inactive IndicationsClostridium Infections

Other Information

ATC CodeN/A
Related LinksN/A